+86-28-82633987
EN
CN EN

Bryonolic acid

SBP00733
24480-45-3
98%
Biopurify
Bryonolic acid has cytotoxic, anti-allergic, anti-inflammatory and antioxidant activities, it can reduce the inflammatory mediator NO by suppressing the expression of the inflammatory enzyme inducible nitric oxide synthase (iNOS) in LPS-activated RAW 264.7 macrophage cells. Bryonolic acid may be a promising neuroprotective agent for the treatment of cerebral ischemia disease, it can protect PC12 cells against NMDA-induced apoptosis by inhibiting Ca2+ influx and regulating gene expression in the Ca2+-CaMKII-CREB signal pathway. 20-epi-bryonolic acid is a pentacyclic triterpenoid of D:C-friedooleanane-type triterpenoids isolated from the stems of Lagenaria siceraria and roots of Coriaria intermedia and has been found to exhibit antineoplastic activity. It has a role as a metabolite and an antineoplastic agent. It is a pentacyclic triterpenoid and a hydroxy monocarboxylic acid.
Catalog No Package Original Price Price Inventory Quantity Operating
SBP00733-5mg 5mg $420.00
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Related targets

Bryonolic acid Related Products

Product drug property prediction parameters

  • 57.5300

  • 6.7452

  • 4.9255

  • .0012

  • 5.8757

  • 4.7754

  • Low

  • 94.0768

  • 4.7794

  • No

  • No

  • No

  • No

  • No

  • No

  • 0.0

  • No

  • No

  • Yes

  • No